Get started
Author

William D. Chow

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis
2013 · Richard T. Silver, William Chow, et al. · Blood · 115
Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade
2015 · William Chow, Clarissa N. Amaya, et al. · JAMA Dermatology · 91
Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma
2018 · Clarissa N. Amaya, Mariah Perkins, et al. · Oncoscience · 51
PDF
Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera
2011 · E. Kuriakose, K. Vandris, et al. · Haematologica · 37
PDF
Results of a Sarcoma Alliance for Research through Collaboration (SARC) phase II trial of dasatinib in previously treated, high-grade, advanced sarcoma.
2010 · S. Schuetze, K. Wathen, et al. · Journal of Clinical Oncology · 35
Prospective Evaluation of the World Health Organization Criteria for the Diagnosis of Polycythemia Vera,
2011 · Richard T. Silver, William Chow, et al. · Blood · 4
Phase I of fixed-dose-rate gemcitabine in combination with bortezomib in patients with advanced solid tumors
2008 · T. H. Luu, W. A. Chow, et al. · Journal of Clinical Oncology · 2
Phase I trial of bortezomib in combination with topotecan in advanced solid tumor malignancies
2006 · R. Morgan, F. Valdes-Albini, et al. · Journal of Clinical Oncology · 2
Abstract 4030: Celsee™ SingleCell Chip can retrieve rare single cells with 100% efficiency for genetic analysis
2017 · Kalyan Handique, Priya Gogoi, et al. · Cancer Research · 1
Phase I study of nelfinavir (NFV) in liposarcoma (LPS).
2010 · W. A. Chow · Journal of Clinical Oncology · 1
Low-frequency bipolar versus high-frequency monopolar cortical and subcortical motor mapping in craniotomies for brain tumors
2026 · William D. Chow, Ali Gharibi Loron, et al. · Journal of neurosurgery
Differential awakening of the sciatic nerve: illustrative case
2026 · William D. Chow, Pavlos Texakalidis, et al. · Journal of Neurosurgery Case Lessons
Prognostic factors for 90-day survival after stereotactic radiosurgery for brain metastasis patients
2026 · Ali Gharibi Loron, William D. Chow, et al. · Journal of neurosurgery
Radt-01. Prognostic Factors for 90-day Survival After Stereotactic Radiosurgery for Brain Metastasis Patients
2025 · Ali Gharibi Loron, William D Chow, et al. · Neuro-Oncology
PDF
Mp55-08 Feasibility of Finding Circulating Tumors Cells and Assigning Pd-l1 Receptor Status Using Single-cell Technology Combined With Celsee Genesis System
2020 · Shaheen Alanee*, Vishal Sharma, et al. · The Journal of Urology
Feasibility of finding circulating tumors cells and assigning PD-L1 receptor status using single-cell technology combined with Celsee Genesis system.
2020 · Shaheen Riadh Alanee, Vishal Sharma, et al. · Journal of Clinical Oncology
Red cell mass (RCM) determination is essential for proper diagnosis of early stage polycythemia vera (PV)
2012 · Stephen P. Arles, William Chow, et al. · Journal of Nuclear Medicine
Bone Marrow Histology and Red Cell Mass Allow Accurate Identification of Early Stage Polycythemia Vera
2012 · Attilio Orazi, Leonardo Boiocchi, et al.
A phase I study of bortezomib (BTZ) and temozolomide (TMZ) in patients with advanced solid tumors.
2010 · J. Portnow, S. Koehler, et al. · Journal of Clinical Oncology
Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGF-Rα-expressing Ewing sarcoma family of tumors (ESFT) and desmoplastic small round cell tumors (DSRCT)
2008 · J. Chao, G. T. Budd, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 339
H-index: 5
I10-index: 5
Year
Topic
Type